Announced Tue, 27 May · 18:48 IST

Submission of intimation of appointment of internal Auditor of the Company.

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) has informed BSE that its Board of Directors, at a meeting held on May 27, 2025, approved the re-appointment of M/s V R P S & Co., Chartered Accountants (FRN: 006340S) as Internal Auditors for the financial year 2025-26. The appointment is being made to comply with the Companies Act, 2013 and SEBI Listing Regulations. The firm is described as a multi-sector professional services outfit and is not related to any directors or key managerial personnel of the company. The board meeting lasted from 5:00 PM to 5:30 PM on the same day.

Likely market impact

This is a routine corporate governance compliance update with no material impact on shareholders or stock price. Re-appointment of the same internal auditor signals continuity in audit oversight for the upcoming financial year.